Dr. Therese B. Bevers is professor of Clinical Cancer Prevention and the medical director of the Cancer Prevention Center and prevention outreach programs at M. D. Anderson Cancer Center. In her role as medical director, Dr. Bevers has overseen the growth and program development of the Cancer Prevention Center—the first comprehensive clinical cancer prevention service program in the country—since its opening in 1996.
Her clinical and research interests are in the area of breast cancer prevention, screening, diagnosis and survivorship. She was an investigator on the groundbreaking Breast Cancer Prevention Trial which demonstrated that tamoxifen reduced the risk of developing breast cancer by one half and currently serves as the institutional principal investigator (PI) for the STAR trial which showed that raloxifene had similar benefits but fewer risks. She is currently the institutional PI of a breast cancer prevention study of polyphenon E, an active substance of green tea, in women at increased risk for breast cancer. In addition, she is collaborating on a breast cancer prevention study of Lipitor, a cholesterol-lowering drug, in women at increased risk for breast cancer. Dr. Bevers chairs the National Comprehensive Cancer Network’s guideline panels on Breast Cancer Screening and Diagnosis and Breast Cancer Risk Reduction.
A native Texan, Dr. Bevers completed her medical school and residency in Family Practice at The University of Texas Health Science Center at San Antonio. She is the recipient of many awards including the Julie and Ben Rogers Award for Excellence in Prevention in 2006.